ロード中...
Yangxinkang tablet protects against cardiac dysfunction and remodelling after myocardial infarction in rats through inhibition of AMPK/mTOR-mediated autophagy
CONTEXT: Acute myocardial infarction (AMI) is defined as myocardial necrosis. Clinicians use the traditional Chinese patent medicine Yangxinkang Tablet (YXK) to treat chronic heart failure. OBJECTIVE: To explore the effects of YXK on heart injury following AMI and the underlying mechanisms. MATERIAL...
保存先:
| 出版年: | Pharm Biol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7178820/ https://ncbi.nlm.nih.gov/pubmed/32285737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13880209.2020.1748662 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|